Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glenmark Pharmaceuticals has informed that the Board at its Meeting held on November 2, 2017 has approved the appointment of V. S. Mani as President & Global Chief Financial Officer with effect from November 16, 2017 upon the recommendation of the Nomination and Remuneration Committee. P Ganesh, current President and Global Chief Financial Officer, has tendered his resignation to explore an opportunity outside the Company. The Board places on record its appreciation for contribution made by P Ganesh.
The above information is a part of company’s filings submitted to BSE.
